Home
About DL
Company Profile
Corporate culture
Qualifications and Honors
Product Solution
Clinical Microbiological Diagnosis
Industrial Microbial Testing
User Services
News Updates
DL Information
Contact DL
MALDI‑TOF MS Search
Exhibition Activities
The company has successfully passed the re‑evaluation for High‑Tech Enterprise status.
Recently, our company successfully passed the re‑evaluation for High‑Tech Enterprise status and was awarded the “High‑Tech Enterprise Certificate” jointly issued by the Guangdong Provincial Department of Science and Technology, the Department of Finance, the State Taxation Administration, and the Local Taxation Administration. This successful re‑certification means that from 2012 to 2014, the company will continue to benefit from a three‑year preferential corporate income tax policy, which will help enhance and promote our brand image, support our production and operations, and provide a stronger platform for the company’s leap‑frog development. The smooth passing of this re‑examination once again demonstrates that Dier Medical has achieved significant improvements and advancements in areas such as R&D project initiation, capital investment, and the commercialization of research outcomes. Moving forward, Dier…
28
2012
/
02
Director Zhao Wangsheng, a microbiology expert from Jiangsu Provincial People’s Hospital, and his delegation paid a visit to our company.
On March 17–18, accompanied by Mr. Lin Huaqing, Chairman of the company, and Director Yin Hong of the Eastern Region, a delegation comprising Associate Chief Physician Zhao Wangsheng, a microbiology expert from the Department of Laboratory Medicine at Jiangsu Provincial People’s Hospital; Director Wu from the Department of Laboratory Medicine at Lianyungang Municipal People’s Hospital; Director Chen from the Department of Laboratory Medicine at Taizhou First Hospital; Director Liu from Dafeng Municipal People’s Hospital; and Director Wang from Jianhu County Hospital, paid a visit to our company to provide guidance. They conducted a detailed on-site inspection of our R&D and production processes, commended our efforts to reduce costs for hospitals through domestically produced bacterial identification and blood culture equipment—thereby delivering greater benefits to patients—and expressed strong approval. They also offered suggestions for further advancing our technology and catching up with comparable imported products.
20
03
Dier has been awarded the title of “Guangdong Province’s 2011 Class A Medical Device Manufacturer for Quality and Credit.”
The Guangdong Provincial Food and Drug Administration has released the 2011 list of Class A medical device manufacturers recognized for their quality and creditworthiness. A total of 97 enterprises across the province were awarded this designation, with Dier once again making the list. Starting in 2011, in accordance with the “Opinions on the Classification-Based Supervision of Medical Device Manufacturers’ Quality and Creditworthiness in Guangdong Province,” the Guangdong Provincial Food and Drug Administration categorized medical device manufacturers within the province into three classes—A, B, and C. Enterprises that strictly comply with relevant laws, regulations, and rules governing the supervision and administration of medical devices, maintain an effectively functioning quality management system, and meet all requirements in key areas during routine inspections are eligible for classification as Class A.
11
04
Dier successfully passed the ISO 9001:2008 and ISO 13485:2003 quality management system certifications during the 2012 surveillance audit.
Since establishing its quality management system in 2006, our company has placed great emphasis on quality management at the highest levels of corporate leadership. All employees have kept the customer at the center of their efforts, fulfilled all management commitments, and actively participated in the establishment, maintenance, promotion, and continuous improvement of the quality management system, ensuring its sustained and effective operation. On June 20–21, 2012, our company successfully underwent a surveillance audit conducted by an assessment team dispatched by Beijing Guoyi Xie Huaguang Certification Co., Ltd., which evaluated whether our quality management system, established in accordance with GB/T 19001-2008 and YY/T 0287-2003, was operating effectively. This…
22
06
Experts from Jiangxi Provincial People’s Hospital paid a visit to our company to provide guidance.
We warmly welcome the experts from Jiangxi Provincial People’s Hospital to our company for a visit and guidance.
17
07